<DOC>
	<DOCNO>NCT02022020</DOCNO>
	<brief_summary>This study conduct collect data management gastrointestinal urogenital bleeding event occur patient atrial fibrillation take dabigatran etexilate .</brief_summary>
	<brief_title>Management Gastrointestinal Urogenital ( GI/GU ) Bleedings Atrial Fibrillation Patients Using Pradaxa</brief_title>
	<detailed_description>Purpose :</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Inclusion criterion : &gt; =18 year age ; Confirmed diagnosis Atrial Fibrillation ( AF ) ; Documentation patient acute GI and/or GU bleeding event take least one dose dabigatran prior event . Exclusion criterion : Confirmed diagnosis valvular AF ( VAF ) ; Documentation patient take dabigatran oral anticoagulant ; Documentation patient receive thrombolytic therapy prior event ; Documentation patient enrol investigational clinical trial time event ; Medical record available .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>